SABS
SAB Biotherapeutics Inc.
$3.71
-$0.05(-1.33%)
44
Overall
60
Value
40
Tech
34
Quality
Market Cap
$33.32M
Volume
154.36K
52W Range
$1.05 - $6.60
Target Price
$9.50
Company Overview
| Mkt Cap | $33.32M | Price | $3.71 |
| Volume | 154.36K | Change | -1.33% |
| P/E Ratio | -1.0 | Open | $3.83 |
| Revenue | $1.3M | Prev Close | $3.76 |
| Net Income | $-34.1M | 52W Range | $1.05 - $6.60 |
| Div Yield | N/A | Target | $9.50 |
| Overall | 44 | Value | 60 |
| Quality | 34 | Technical | 40 |
No chart data available
Latest News
SAB Biotherapeutics Highlights New Phase 1 SAB-142 Data
TipRanks Auto-Generated Newsdesk•a month ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
Catie Powers•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SABS | $3.71 | -1.3% | 154.36K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get SAB Biotherapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW